VRANIC, S. Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes. Biomolecules and Biomedicine, [S. l.], v. 23, n. 2, p. 189–190, 2023. DOI: 10.17305/bb.2022.8874. Disponível em: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8874. Acesso em: 25 mar. 2023.